To determine the value of chest and skeletal staging in patients with parosteal osteosarcoma (POS), and the incidence of late local and chest recurrence.
Materials and methods
Retrospective review of patients across two institutions with histological confirmation of POS diagnosed between January 2007 and March 2020. Data collected included age, sex, skeletal location, results of chest CT and whole-body bone scintigraphy (WB-BSc) or whole-body MRI (WB-MRI) obtained at initial diagnosis. The histological tumour grade based on surgical resection specimens was classified as low-grade POS (LG-POS) and dedifferentiated POS (DD-POS). Findings of chest CT and skeletal staging were correlated with tumour grade. Follow-up chest CT and MRI studies were reviewed to determine the rate of late lung metastases and local recurrence.
There were 27 males and 44 females, mean age 33 years (range 12–79 years). The femur (n = 43) and tibia (n = 14) were the most commonly involved bones. From surgical resection histology, 42 (59.2%) were LG-POS and 29 (40.8%) were DD-POS. WB-BSc/WB-MRI showed no skeletal metastases, while 1 case of DD-POS presented with bilateral calcified lung metastases. At follow-up, 7 patients (9.9%) developed lung metastases (mean of 18.9 months, range 10–48 months) from initial presentation, of which all were DD-POS. All but 1 patient who developed subsequent lung metastases had a local recurrence.
Skeletal staging is unlikely to be of value in POS. Staging chest CT is very unlikely to demonstrate lung metastases in LG-POS and could be limited to DD-POS, particularly at the time of local recurrence.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Klein MJ, Siegal GP. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol. 2006;125(4):555–81.
Misaghi A, Goldin A, Awad M, Kulidjian AA. Osteosarcoma: a comprehensive review. SICOT J. 2018;4:12.
Hang JF, Chen PC. Parosteal osteosarcoma. Arch Pathol Lab Med. 2014 May;138(5):694–9.
Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon, France: IARC Press; 2013.
Miller BJ, Cram P, Lynch CF, Buckwalter JA. Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database. J Bone Joint Surg Am. 2013;95(13):e89.
Gerrand C, Athanasou N, Brennan B, et al. UK guidelines for the management of bone sarcomas. Clin Sarcoma Res BioMed Central. 2016;6(1):7.
Casali PG, Bielack S, Abecassis N et al. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct;29 Suppl 4:iv79-iv95.
Bertoni F, Bacchini P, Staals EL, et al. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute. Cancer. 2005;103(11):2373–82.
Jelinek JS, Murphey MD, Kransdorf MJ, et al. Parosteal osteosarcoma: value of MR imaging and CT in the prediction of histologic grade. Radiology. 1996;201:837–42.
Okada F, Frassica FJ, Sim FH, et al. Parosteal osteosarcoma: a clinicopathological study. J Bone Joint Surg Am. 1994;76(3):366–78.
Cassone AEm Camargo OP, Croci AT, et al. Paraosteal osteosarcoma. Rev Bras Ortop. 1998; 33 (11).
Unni KK, Dahlin DC, Beabout JW, et al. Parosteal osteogenic sarcoma. Cancer. 1976;37:2466–75.
Hoshi M, Matsumoto S, Manabe J. Oncologic outcome of parosteal osteosarcoma. Int J Clin Oncol. 2006;11(2):120–6.
Lin HY, Hondar Wu HT, Wu PK, et al. Can imaging distinguish between low-grade and dedifferentiated parosteal osteosarcoma? J Chin Med Assoc. 2018;81(10):912–9.
Song WS, Jeon DG, Cho WH, et al. Clinical outcome of paraosteal osteosarcoma. J Korean Bone Joint Tumor Soc. 2013;19(1):20–7.
Lindell MM Jr, Shirkhoda A, Raymond AK, Murray JA, Harle TS. Parosteal osteosarcoma: radiologic-pathologic correlation with emphasis on CT. AJR Am J Roentgenol. 1987;148:323–8.
Tariq MU, Uddin N, Ahmed A. Challenges and pitfalls in diagnosis of paraosteal osteosarcoma: a clinicopathologic study of 23 cases. Journal of Solid Tumours. 2016;6(2):17–24.
Levine E, De Smet AA, Huntrakoon M. Juxtacortical osteosarcoma: a radiologic and histologic spectrum. Skelet Radiol. 1985;14(1):38–46.
Schajowicz F, McGuire MH, Santini Araujo E, et al. Osteosarcomas arising on the surfaces of long bones. J Bone Joint Surg Am. 1988;70:555–64.
Ritschl P, Wurnig C, Lechner G, et al. Parosteal osteosarcoma. 2–23-year follow-up of 33 patients. Acta Orthop Scand. 1991;62(3):195–200.
Sheth DS, Yasko AW, Raymond AK, et al. Conventional and dedifferentiated parosteal osteosarcoma. Diagnosis, treatment, and outcome. Cancer. 1996;78(10):2136–45.
Funovics PT, Bucher F, Toma CD, et al. Treatment and outcome of parosteal osteosarcoma: biological versus endoprosthetic reconstruction. J Surg Oncol. 2011;103(8):782–9.
Han I, Oh JH, Na YG, et al. Clinical outcome of parosteal osteosarcoma. J Surg Oncol. 2008;97(2):146–9.
Temple HT, Scully SP, O'Keefe RJ, et al. Clinical outcome of 38 patients with juxtacortical osteosarcoma. Clin Orthop Relat Res. 2000;373:208–17.
Takeuchi K, Morii T, Yabe H, et al. Dedifferentiated parosteal osteosarcoma with well-differentiated metastases. Skelet Radiol. 2006;35(10):778–82.
Nodomi S, Umeda K, Okamoto T, et al. A pediatric case of metastatic conventional Parosteal osteosarcoma treated with multidrug chemotherapy. Pediatr Blood Cancer. 2016;63(8):1471–3.
Caparica R, Mak MP, Rocha CH, et al. Pulmonary nodules in patients with non-pulmonary cancer: not always metastases. J Glob Oncol. 2016;2(3):138–44.
Ghosh KM, Lee LH, Beckingsale TB, et al. Indeterminate nodules in osteosarcoma: what’s the follow-up? Br J Cancer. 2018;118(5):634–8.
Jackson JB 3rd, Kneisl JS. Parosteal osteosarcoma of the 2nd metatarsal. Am J Orthop (Belle Mead NJ). 2013;42(12):557–560.
Tozum H, Aydemir AN, Demiroglu M, Ozkan K, Ceyran AB, Kılıc B. A rare rib lesion due to parosteal osteosarcoma: a case report. J Med Case Rep. 2019;13(1):19.
Sanghavi S, Wahegaonkar A, Panchwagh Y, Kharat A. Parosteal osteosarcoma of the distal radius mimicking an osteochondroma-a diagnostic misadventure. J Hand Surg Am. 2017;42(12):1038.e1–1038.e10.
Gupta S, Parikh S, Goel S. Parosteal osteosarcoma of mandible: a rare case report. J Cancer Res Ther. 2018;14(2):471–4.
Kumar VS, Barwar N, Khan SA. Surface osteosarcomas: diagnosis, treatment and outcome. Indian J Orthop. 2014;48(3):255–61.
Xie L, Huang W, Wang H, et al. Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study. J Orthop Surg Res. 2020;15(1):32.
Jeffree GM, Price CH, Sissons HA. The metastatic patterns of osteosarcoma. Br J Cancer. 1975;32(1):87–107.
Salah S, Ahmad R, Sultan I. Osteosarcoma with metastasis at initial diagnosis: current outcomes and prognostic factors in the context of a comprehensive cancer center. Molecular and Clinical Oncology. 2014;2:811–6.
Liu F, Zhang Q, Zhou D, et al. Effectiveness of 18F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies. BMC Cancer. 2019;19(1):323.
Hurley C, McCarville MB, Shulkin BL, et al. Comparison of (18) F-FDG-PET-CT and bone scintigraphy for evaluation of osseous metastases in newly diagnosed and recurrent osteosarcoma. Pediatr Blood Cancer. 2016;63(8):1381–6.
Conflict of interest
The authors declare that they have no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Rajakulasingam, R., Attard, V., Botchu, R. et al. The value of chest and skeletal staging in parosteal osteosarcoma: two-centre experience and literature review. Skeletal Radiol 50, 301–309 (2021). https://doi.org/10.1007/s00256-020-03557-y
- Parosteal osteosarcoma
- Chest CT
- Whole-body bone scintigraphy
- Whole-body MRI